Näytetään 1 - 3 yhteensä 3 tuloksesta haulle 'A. E. van Leeuwen', hakuaika: 0,02s Tarkenna hakua
  1. 1
    Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design

    Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design Tekijä A. Klaassen-Dekker, C. H. C. Drossaert, M. C. Van Maaren, A. E. Van Leeuwen-Stok, V. P. Retel, J. C. Korevaar, S. Siesling, on behalf of the NABOR project group

    Julkaistu 2023-11-01
    Hae kokoteksti
    Artikkeli
  2. 2
    Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade

    Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade Tekijä M. C. Liefaard, A. van der Voort, M. van Seijen, B. Thijssen, J. Sanders, S. Vonk, L. Mittempergher, R. Bhaskaran, L. de Munck, A. E. van Leeuwen-Stok, R. Salgado, H. M. Horlings, E. H. Lips, G. S. Sonke

    Julkaistu 2024-04-01
    Hae kokoteksti
    Artikkeli
  3. 3
    BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer

    BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer Tekijä M. C. Liefaard, A. van der Voort, M. S. van Ramshorst, J. Sanders, S. Vonk, H. M. Horlings, S. Siesling, L. de Munck, A. E. van Leeuwen, M. Kleijn, L. Mittempergher, M. M. Kuilman, A. M. Glas, J. Wesseling, E. H. Lips, G. S. Sonke

    Julkaistu 2023-06-01
    Hae kokoteksti
    Artikkeli

Työkalut: